A clinical investigation of a new gelling fibre dressing containing silver for the management of partial-thickness burns
Journal of Wound Care · 02.10.2025 · 34 (10) · 797-804
DOI: 10.12968/jowc.2025.0233 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Wound Care, erschienen am 02.10.2025. Verfasst von Christopher J Lewis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Northern Regional Burn Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: Anti-Infective Agents, Local, Bandages, Burns, Silver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate the performance and safety of Biatain Fiber Ag (Coloplast A/S, Denmark), a new gelling fibre wound dressing containing silver, based on percentage of wounds healed in partial-thickness burns within two weeks.
Method
This non-comparative, one-armed, open-labelled, multicentre study, included patients from five different sites in the UK between October 2023 and April 2024. The primary endpoint was whether a wound healed or not. Adverse events were also assessed.
Results
In total, 51 patients with a partial-thickness burn wound that was either infected or at risk of infection, and with medium-to-high levels of exudate, were part of the full analysis set. The proportion of wounds healed within two weeks of treatment was 83.7% (95% confidence interval (CI): 69.3, 93.2) of the 43 patients completing the investigation. In a post hoc sensitivity analysis, assuming that missing data on wound healing were either missing at random or corresponded to a non-healed wound, the estimated proportion of wounds healed was 74.8% (95% CI: 60.7, 85.1). In the pre-planned sensitivity analysis, where all missing data on wound healing were assumed to correspond to a non-healed wound, it was 70.6% (95% CI: 56.2, 82.5). A total of seven adverse events were found related to the investigational device; all were non-serious.
Conclusion
In this study, treatment of partial-thickness burns with the investigational device showed that the percentage of healed wounds within two weeks was comparable to the performance of similar products. In addition, the results revealed no safety concerns. This new gelling fibre wound dressing containing silver may therefore have a notable clinical implication for wound healing in patients with acute wounds that are infected or at risk of infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Northern Regional Burn Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
- Coloplast A/S, Humlebaek, Denmark.
- Queen Victoria Hospital NHS Foundation Trust, West Sussex, UK.
- Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
- Whiston Hospital, Mersey and West Lancashire Teaching Hospital NHS Trust, Prescot, UK.
- Stoke Mandeville Hospital, Buckinghamshire Healthcare NHS Trust, Aylesbury, UK.
ORCID-Profile: Malene Høj Outzen
Zitieren
APA
Lewis, C. J., Outzen, M. H., Hindsberger, C., Dheansa, B., Wearn, C., Shokrollahi, K., Pinto, J., Gjødsbøl, K., & Issa, F. (2025). A clinical investigation of a new gelling fibre dressing containing silver for the management of partial-thickness burns. Journal of Wound Care, 34(10), 797-804. https://doi.org/10.12968/jowc.2025.0233
Vancouver
Lewis CJ, Outzen MH, Hindsberger C, Dheansa B, Wearn C, Shokrollahi K, et al. A clinical investigation of a new gelling fibre dressing containing silver for the management of partial-thickness burns. Journal of Wound Care. 2025;34(10):797-804. doi:10.12968/jowc.2025.0233
BibTeX
@article{Lewis2025,
author = {Lewis, Christopher J and Outzen, Malene Høj and Hindsberger, Charlotte and Dheansa, Baljit and Wearn, Christopher and Shokrollahi, Kayvan and Pinto, Joana and Gjødsbøl, Kristine and Issa, Fadi},
title = {A clinical investigation of a new gelling fibre dressing containing silver for the management of partial-thickness burns},
journal = {Journal of Wound Care},
year = {2025},
volume = {34},
number = {10},
pages = {797--804},
doi = {10.12968/jowc.2025.0233}
}
EUVIMED